Skye Bioscience, Inc. SEC filings SKYE
Skye Bioscience, Inc. has 631 filings in SEC EDGAR's recent list, going back to Mar 25, 2011. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 11, 2026 (agreement ended, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Filing | Oct 28, 2026 | — |
| PREM14A | Filing | Oct 26, 2026 | Oct 26, 2026 |
| DEFA14A | Additional proxy material | Sep 11, 2026 | — |
| 8-K |
Current report
Agreement ended, Officer or director change, Other events
|
Sep 11, 2026 | Sep 8, 2026 |
| DEFA14A | Additional proxy material | Aug 24, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 24, 2026 | Aug 21, 2026 |
| DEFA14A | Additional proxy material | Aug 20, 2026 | — |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Aug 20, 2026 | Aug 12, 2026 |
| DEFA14A | Additional proxy material | Aug 19, 2026 | — |
| 8-K |
Current report
Listing notice
|
Aug 19, 2026 | Aug 18, 2026 |
| DEFA14A | Additional proxy material | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 29, 2026 | May 26, 2026 |
| 8-K |
Current report
Listing notice
|
May 15, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| PREM14A | Def 14a | Apr 6, 2026 | Apr 6, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 19, 2026 | Mar 17, 2026 |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 20, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Auditor change, Shareholder vote results
|
Jun 11, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2025 | Feb 24, 2025 |
| UPLOAD | Letter from the SEC | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 24, 2024 | Oct 22, 2024 |
| DEF 14A | Proxy statement | Sep 23, 2024 | Sep 23, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Sep 13, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 4, 2024 | Sep 3, 2024 |
| S-8 | Employee stock plan registration | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 3, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 10, 2024 | Jun 10, 2024 |
| EFFECT | Filing | May 17, 2024 | — |
| EFFECT | Filing | May 17, 2024 | — |
| 424B3 | Prospectus | May 17, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| EFFECT | Filing | Apr 26, 2024 | — |
| POS AM | Filing | Apr 24, 2024 | — |
| EFFECT | Filing | Apr 10, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| CERT | Filing | Apr 10, 2024 | — |
| 8-A12B | Filing | Apr 10, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| S-1/A | Amended registration statement | Apr 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2024 | Apr 3, 2024 |
| UPLOAD | Letter from the SEC | Apr 2, 2024 | — |
| S-1 | Registration statement | Mar 27, 2024 | — |
| D | Filing | Mar 27, 2024 | — |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 13, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 4, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 12, 2024 | Feb 12, 2024 |
| D | Filing | Feb 12, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| S-8 | Employee stock plan registration | Dec 22, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 5, 2023 | Nov 29, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 7, 2023 | Nov 6, 2023 |
| DEF 14C | Information statement | Oct 17, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 3, 2023 | Sep 29, 2023 |
| PRE 14C | Filing | Oct 3, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 7, 2023 | Sep 6, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 1, 2023 | Aug 15, 2023 |
| D | Filing | Aug 29, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Aug 21, 2023 | Aug 15, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 27, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Feb 23, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 16, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Other events
|
Feb 15, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 27, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 6, 2023 | Dec 30, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 19, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Nov 23, 2022 | Nov 17, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 19, 2022 | Oct 14, 2022 |
| 8-K |
Current report
Auditor change, Shareholder vote results, Regulation FD disclosure
|
Oct 3, 2022 | Sep 29, 2022 |
| DEFA14A | Additional proxy material | Sep 1, 2022 | — |
| DEFM14A | Filing | Aug 31, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| PREM14A | Filing | Aug 15, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 21, 2022 | Jul 15, 2022 |
| 8-K |
Current report
Material agreement, Auditor change, Officer or director change
|
Jun 17, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change
|
May 23, 2022 | May 18, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
May 12, 2022 | May 11, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 20, 2021 | Dec 14, 2021 |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 15, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 6, 2021 | Oct 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2021 | Sep 29, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 28, 2021 | Sep 27, 2021 |
| 424B5 | Prospectus supplement | Sep 28, 2021 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 15, 2021 | Sep 14, 2021 |
| EFFECT | Filing | Aug 9, 2021 | — |
| 424B3 | Prospectus | Aug 6, 2021 | — |
| 10-Q | Quarterly report | Aug 6, 2021 | Jun 30, 2021 |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2021 | — |
| S-3 | Shelf registration | Jul 29, 2021 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 26, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 22, 2021 | Jul 21, 2021 |
| 424B3 | Prospectus | May 7, 2021 | — |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 424B3 | Prospectus | Mar 2, 2021 | — |
| 10-K | Annual report | Mar 2, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Feb 3, 2021 | Jan 28, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jan 19, 2021 | Jan 19, 2021 |
| DEF 14A | Proxy statement | Dec 22, 2020 | Dec 22, 2020 |
| PRE 14A | Preliminary proxy statement | Dec 11, 2020 | Dec 10, 2020 |
| 424B3 | Prospectus | Nov 9, 2020 | — |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2020 | Sep 25, 2020 |
| 424B3 | Prospectus | Aug 13, 2020 | — |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| S-8 | Employee stock plan registration | Aug 13, 2020 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 12, 2020 | Aug 7, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 5, 2020 | Jul 31, 2020 |
| 424B4 | Prospectus | Aug 3, 2020 | — |
| EFFECT | Filing | Jul 31, 2020 | — |
| S-1MEF | Form s-1mef | Jul 31, 2020 | — |
| CORRESP | Letter to the SEC | Jul 29, 2020 | — |
| S-1/A | Amended registration statement | Jul 28, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2020 | — |
| S-1 | Registration statement | Jul 13, 2020 | — |
| 8-K |
Current report
New debt
|
Jun 22, 2020 | Jun 17, 2020 |
| 424B3 | Prospectus | May 8, 2020 | — |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Apr 29, 2020 | Apr 29, 2020 |
| 424B3 | Prospectus | Mar 23, 2020 | — |
| 10-K | Annual report | Mar 23, 2020 | Dec 31, 2019 |
| EFFECT | Filing | Mar 17, 2020 | — |
| POS AM | Filing | Mar 13, 2020 | — |
| EFFECT | Filing | Feb 13, 2020 | — |
| POS AM | Filing | Feb 13, 2020 | — |
| POS AM | Filing | Feb 11, 2020 | — |
| POS AM | Filing | Jan 22, 2020 | — |
| EFFECT | Filing | Dec 31, 2019 | — |
| POS AM | Filing | Dec 24, 2019 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change, Other events
|
Dec 23, 2019 | Dec 17, 2019 |
| AW | Filing | Dec 17, 2019 | — |
| POS AM | Filing | Dec 9, 2019 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2019 | Nov 21, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Nov 20, 2019 | Nov 19, 2019 |
| 424B3 | Prospectus | Nov 14, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2019 | — |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 424B4 | Prospectus | Nov 13, 2019 | — |
| S-1MEF | Form s-1mef | Nov 13, 2019 | — |
| DEF 14C | Information statement | Oct 30, 2019 | Oct 28, 2019 |
| EFFECT | Filing | Oct 28, 2019 | — |
| CORRESP | Letter to the SEC | Oct 25, 2019 | — |
| S-1/A | Amended registration statement | Oct 23, 2019 | — |
| 8-K |
Current report
Material agreement
|
Aug 27, 2019 | Aug 23, 2019 |
| SEC STAFF LETTER | Filing | Aug 23, 2019 | — |
| 8-K |
Current report
Other events
|
Aug 23, 2019 | Aug 21, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SKYE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1516551
- Former names
- Emerald Bioscience, Inc. (until Jan 7, 2021); Nemus Bioscience, Inc. (until Mar 14, 2019); LOAD GUARD LOGISTICS, INC. (until Oct 30, 2014); LOAD GUARD TRANSPORTATION, INC. (until Nov 7, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.